Hubei Pioneers Pricing Standards for Brain-Computer Interface Medical Services
Hubei establishes China’s first pricing standards for brain-computer interface treatments, accelerating clinical adoption of neurotechnology across healthcare systems.
HealthcareInnovation
Read More
AstraZeneca CEO Hails China’s ‘Uncommon’ Support for Businesses
AstraZeneca CEO Pascal Soriot commends China’s unique governmental backing for businesses, emphasizing collaboration in healthcare and economic growth.
China Sets Pricing Standards for Brain-Computer Interface Tech
China releases BCI pricing guidelines, advancing clinical integration for paralysis treatment and neurotech innovation.
NPC Deputy Highlights AI Infrastructure to Boost Chinese Mainland’s Industry and Healthcare
An NPC Deputy emphasizes the importance of strengthening AI infrastructure to enhance the Chinese mainland’s industry and healthcare sectors amid upcoming legislative sessions.